Bonviva 3mg/3ml Solution for Injection is an intravenous bisphosphonate that reduces bone loss by inhibiting osteoclast-mediated bone resorption. It is intended for postmenopausal women with osteoporosis and has been shown to reduce the risk of vertebral fractures.
The medicine is administered as a slow intravenous injection over 15–30 seconds every three months by a qualified healthcare professional. Patients should receive adequate calcium and vitamin D supplementation where required throughout treatment.
Key Benefits
- Helps increase bone mineral density
- Reduces vertebral fracture risk
- Convenient once-every-three-month dosing
- Suitable for patients unable to take oral bisphosphonates
- Long-term osteoporosis management
Uses
- Treatment of osteoporosis in postmenopausal women at increased risk of fracture.
Active Ingredients
- Ibandronic acid 3 mg/3 ml
How to Take
- Administered by intravenous injection over 15–30 seconds.
- Given once every three months by a healthcare professional.
- Ensure adequate calcium and vitamin D intake during treatment.
Precautions
- Prescription-only medicine.
- Existing hypocalcaemia should be corrected before treatment.
- Use cautiously in patients with severe renal impairment.
- Maintain good oral hygiene and report jaw pain or dental symptoms promptly.
